Panic Disorders Market Poised for 5.7 % Growth, Set to Hit $5.81 Billion by 2029

What market dynamics are playing a key role in accelerating the growth of the panic disorders market?
The upward trend of people suffering from psychiatric disorders is projected to fuel the expansion of the panic disorder market. Psychiatric patients, dealing with mental illnesses or psychiatric disorders, often experience disruption in cognition, emotions, and social behavior, culminating in panic disorder or sudden severe panic attacks. The customary treatment for these patients involves a blend of therapeutic regimes, prescription drugs, and adjustments in lifestyle to mitigate panic attack symptoms, enhance the patient's overall health and wellbeing and aid in the efficient management of the disorder. To illustrate, in October 2022, the State of Mental Health in America 2022 report by Mental Health America, a US non-profit organization concerned with mental health advocacy, indicated a rise in the count of adult psychiatric patients or individuals wrestling with any mental illnesses to 49,564,000, multiple of 19.86% of the total populace in 2022 in the US, in contrast to 47,132,000, a proportion of 19.00% of the total populace in 2021. Consequently, the rising number of psychiatric patients is anticipated to catalyze the growth of the panic disorder market. The transformative effect of telehealth on the panic disorders market stands as a key market driver. Telehealth's escalating usage is predicted to further boost the panic disorder market's growth. Utilizing electronic communication technologies like videoconferencing, phone calls, and secure message exchange to provide remote healthcare facilities and consultations is what telehealth is all about. Telehealth makes psychotherapy and counselling services accessible to individuals suffering from panic disorders. Therapists are enabled to facilitate individual or group therapy sessions and support groups over secure videoconferencing platforms through telehealth. In a report from FAIR Health Inc., a US-based non-profit organization, in April 2023, a national surge of 7.3% was observed in telehealth usage, indicating a leap from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Hence, the amplifying usage of telehealth implies an upward momentum for the panic disorders market.

Get Your Panic Disorders Market Report Here:
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

How will the growth rate of the panic disorders market shape industry trends by 2034?
In the past few years, the market size for panic disorders has been expanding consistently. Projected growth from $10.73 billion in 2024 to $11.19 billion in 2025 reveals a compound annual growth rate (CAGR) of 4.3%. Factors such as the use of antidepressant medicines, enhanced knowledge about mental health, rising stress levels, better access to mental health facilities, and progress in diagnostic standards account for the expansion during the historical period.

In the coming years, the market size for panic disorders is projected to see substantial growth. It is set to reach $13.96 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. The predicted growth throughout the forecast period can be attributed to factors such as the emergence of new pharmacological treatments, the rise of telepsychiatry services, emphasis on comorbidities, global initiatives promoting mental health, the use of pharmacogenomics in treatment processes, and public educational programs. The forecast period is expected to bring key trends such as the incorporation of digital mental health interventions, the use of telemedicine for treating panic disorders, medical innovations, neurobiological studies, and the advent of remote monitoring and wearable technology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What trends are poised to drive the future success of the panic disorders market?
Top firms in the panic disorder market are concentrating their efforts on creating advanced drugs, such as extended-release capsules, to uphold their market presence. Extended-release capsules provide a gradual release of the active ingredient over a designated period of time, usually over 12 or 24 hours, making them ideal for conditions that require long-term medication. For instance, in May 2023, Granules India Ltd., an Indian pharmaceutical firm, was granted an abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA) for the production of Venlafaxine hydrochloride extended-release capsules. These capsules have been proven to have similar effectiveness to the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, produced by Upjohn US 2 LLC. The capsules, generally started at a dosage of 75 mg per day and increased as necessary, are used to manage a variety of conditions like generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). Their function is to augment the presence of serotonin and norepinephrine in the brain.

Which primary segments of the panic disorders market are driving growth and industry transformations?
The panic disorders market covered in this report is segmented -

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:
1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia
2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety
3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD
4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder
5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD
6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

Which geographical regions are pioneering growth in the panic disorders market?
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the panic disorders market landscape?
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

What Is Covered In The Panic Disorders Global Market Report?

•Market Size Forecast: Examine the panic disorders market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the panic disorders market for a structured understanding.
•Key Players Overview: Analyze major players in the panic disorders market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the panic disorders market.
•Segment Contributions: Evaluate how different segments drive overall growth in the panic disorders market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the panic disorders market.
•Industry Challenges: Identify potential risks and obstacles affecting the panic disorders market.
•Competitive Landscape: Review strategic developments in the panic disorders market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.